Logistic regression analysis of prognostic risk factors for hepatic encephalopathy

Cui YanPing; Li QingFang; Li QingYan; Liu ChunHua; Wang WeiHong; Yuan JianGuo; Wang SiKui

doi:10.3969/j.issn.1001-5256.2016.01.026

Volume 32 Issue 1

Jan. 2016

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2016 > 32(1): 135-138

PDF( 1487 KB)

Logistic regression analysis of prognostic risk factors for hepatic encephalopathy

DOI: 10.3969/j.issn.1001-5256.2016.01.026

Liaocheng People's Hospital

Received Date: 2015-05-11
Published Date: 2016-01-20

Abstract

Abstract

Objective To analyze the prognostic risk factors for hepatic encephalopathy( HE),and to explore the risk factors for prognosis.Methods A total of 385 patients with HE who were treated in Liaocheng People's Hospital from January 2006 to June 2014 were enrolled in this study and analyzed retrospectively. These patients were divided into improved group( n = 125) and deteriorated group( n = 260). A total of 25 clinical indices were selected,and non- conditional binary logistic regression analysis was performed for related data with SPSS.Results Univariate analysis showed that HE stage,upper gastrointestinal hemorrhage,hepatorenal syndrome( HRS),total bilirubin( TBil),and international normalized ratio( INR) were risk factors affecting the prognosis of HE( P = 0. 000,0. 009,0. 047,0. 002,and0. 027,respectively). Multivariate logistic regression analysis was further performed for the variables with statistical significance and the results showed that HE stage,upper gastrointestinal hemorrhage,HRS,TBil,and INR were independent risk factors affecting the prognosis of HE( P = 0. 000,0. 009,0. 000,0. 000,and 0. 008,respectively; OR( 95% CI) = 4. 388( 2. 997- 6. 424),2. 805( 1. 300- 6. 050),4. 036( 2. 018- 8. 072),1. 005( 1. 003- 1. 007),and 1. 446( 1. 099- 1. 901),respectively). Conclusion HE stage,upper gastrointestinal hemorrhage,HRS,TBil,and INR are risk factors affecting the prognosis of HE,and advanced HE stages,a high level of bilirubin,high INR,and presence of upper gastrointestinal hemorrhage and HRS indicate poor prognosis. The patient's HE stage,upper gastrointestinal hemorrhage,HRS,TBil,and INR are applied as the indices for prognosis of HE,and the equation based on the these indices may have a reference value in clinical practice.
- hepatic encephalopathy,
- prognosis,
- risk factors,
- regression analysis

FullText(HTML)

References(12)

References

[1]SHI YY,CUL JG.Progresses of MRI in hepatic encephalopathy[J].Chin J Med Imaging Technol,2014,30(2):291-294.(in Chinese)史勇跃,崔进国.肝性脑病的MR研究进展[J].中国医学影像技术,2014,30(2):291-294.

[2]Expert Committee on the Diagnosis and Treatment of Hepatic Encephalopathy.Expert consensus on the diagnosis and treatment of hepatic encephalopathy[J/CD].Chin J Exp Clin Infect Dis:Electronic Edition,2009,3(4):449-473.(in Chinese)肝性脑病诊断治疗专家委员会.肝性脑病诊断治疗专家共识[J/CD].中华实验和临床感染病杂志:电子版,2009,3(4):449-473.

[3]YU YH,JIANG JN,WU JZ,et al.Logistic regression analysis of prognostic factors for patients with hepatic encephalopathy[J].Chin J Infect Dis,2009,27(5):305-307.(in Chinese)玉艳红,江建宁,吴继周,等.肝性脑病患者预后影响因素的Logistic回归分析[J].中华传染病杂志,2009,27(5):305-307.

[4]HAUSSINGER D,SCHLIESS F.Pathogenetic mechanisms of hepatic encephalopathy[J].Gut,2008,57(8):1156-1165.

[5]LYU RY,LI SX.Study on the risk factors influencing the prognosis of hepatic encephalopathy[J].Chin J Gen Prac,2012,10(11):1687-1688.(in Chinese)吕日英,李仕雄.肝性脑病患者预后的危险因素分析[J].中华全科医学,2012,10(11):1687-1688.

[6]NIE X,HE Y,LI GX,et al.Research on relationship between hepatorenal syndrome and hepatic encephalopathy[J].Chin J Lab Diag,2012,16(3):475-478.(in Chinese)聂鑫,贺勇,李贵星,等.肝肾综合征与肝性脑病的关系研究[J].中国实验诊断学,2012,16(3):475-478.

[7]DING JB,LUO XL,TIAN YM,et al.Logistic regression analysis of prognostic factors for chronic severe hepatitis B[J].Infect Dis Info,2012,25(3):161-163.(in Chinese)丁剑波,罗晓岚,田一梅,等.慢性乙型重型肝炎预后影响因素Logistic回归分析[J].传染病信息,2012,25(3):161-163.

[8]YE PY,YANG ZG,CHEN XR,et al.Risk factors associated with prognosis of progressive stages of acute-on-chronic hepatitis B liver failure[J].J Clin Hepatol,2013,29(4):270-275.(in Chinese)叶佩燕,杨宗国,陈晓蓉,等.HBV相关慢加急性肝衰竭不同分期的预后评价及影响因素分析[J].临床肝胆病杂志,2013,29(4):270-275.

[9]CHEN DF,SUN WJ.Recent advances in understanding the pathogenesis of hepatic encephalopathy[J].Chin J Hepatol,2014,22(2):84-85.(in Chinese)陈东风,孙文静.肝性脑病发病机制的研究进展[J].中华肝脏病杂志,2014,22(2):84-85.

[10]KHUNGAR V,POORDAD F.Hepatic encephalopathy[J].Clin Liver Dis,2012,16(2):301-320.

[11]BANARES R,NEVENS F,LARSEN FS,et al.Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure:the relief trial[J].Hepatology,2013,57(3):1153-1162.

[12]HASSANEIN TI,TOFTENG F,BROWN RS,et al.Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis[J].Hepatology,2007,46(6):1853-1862.

Relative Articles

[1]	Mengya GAO, Qian QIN, Shoujun WANG. Value of atherogenic index of plasma in predicting metabolic associated fatty liver disease in patients with type 2 diabetes mellitus[J]. Journal of Clinical Hepatology, 2023, 39(6): 1325-1331. doi: 10.3969/j.issn.1001-5256.2023.06.012
[2]	Fangfang QIAN, Meiqing DAI, Li ZHAO, Xia DENG, Ling YANG, Jue JIA, Jifang WANG, Dong WANG, Guoyue YUAN. Association between serum alkaline phosphatase and type 2 diabetes mellitus with nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2023, 39(1): 83-88. doi: 10.3969/j.issn.1001-5256.2023.01.013
[3]	Xue WU, Yilian ZHANG, Ping LI, Yuqiang MI. Influence of type 2 diabetes mellitus and fasting insulin level on the risk of spontaneous peritonitis in patients with cirrhotic ascites[J]. Journal of Clinical Hepatology, 2022, 38(7): 1548-1553. doi: 10.3969/j.issn.1001-5256.2022.07.017
[4]	Cheng ZHOU, Ran JIA, Jingjing WEI, Chenlu ZHAO, Dongfang SHANG, Wenxia ZHAO. Risk factors for cognitive impairment associated with nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2022, 38(11): 2592-2595. doi: 10.3969/j.issn.1001-5256.2022.11.031
[5]	Dongxu WANG, Nan NAN, Hao BING, Lianjie LIN. Value of triglyceride-glucose index and body mass index in predicting nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus[J]. Journal of Clinical Hepatology, 2022, 38(5): 1064-1068. doi: 10.3969/j.issn.1001-5256.2022.05.017
[6]	Dongxu WANG, Chuan XING, Bo LYU, Han ZHAO, Bing HE. Risk factors for polycystic ovary syndrome with nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2021, 37(10): 2474-2477. doi: 10.3969/j.issn.1001-5256.2021.10.046
[7]	Zhenzhen ZHANG, Yaoyi ZHANG, Kai WANG, Chenguang TIAN. Effect of dapagliflozin on metabolic markers and autonomic function in patients with type 2 diabetes mellitus and metabolic associated fatty liver disease[J]. Journal of Clinical Hepatology, 2021, 37(12): 2849-2853. doi: 10.3969/j.issn.1001-5256.2021.12.023
[8]	Peiru LEI, Yingjie LI, Jing LI. Clinical significance of homocysteine and neutrophil-to-lymphocyte ratio in patients with nonalcoholic fatty liver disease and type 2 diabetes mellitus[J]. Journal of Clinical Hepatology, 2021, 37(10): 2352-2356. doi: 10.3969/j.issn.1001-5256.2021.10.019
[9]	Chaomei QIN, Yongming LIU, Heling SU. Association of hepatitis B and hepatitis C with type 2 diabetes mellitus[J]. Journal of Clinical Hepatology, 2021, 37(4): 921-924. doi: 10.3969/j.issn.1001-5256.2021.04.042
[10]	Renshu MA, Tong WU, Ge YU, Ying CONG, Guijie XIN. A case of type 2 diabetes with glycogenic hepatopathy[J]. Journal of Clinical Hepatology, 2021, 37(9): 2183-2184. doi: 10.3969/j.issn.1001-5256.2021.09.035
[11]	Jiao LIU, Caiqin REN, Yali FENG, Jirui HE. Association between liver fibrosis and C-peptide in patients with type 2 diabetes and nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2021, 37(5): 1132-1136. doi: 10.3969/j.issn.1001-5256.2021.05.030
[12]	Xie HaiPing, Lin Fan, Chen Yan, Zheng Ming. Advances in liraglutide in the treatment of type 2 diabetes with nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2020, 36(9): 2111-2114. doi: 10.3969/j.issn.1001-5256.2020.09.046
[13]	Tian Tian, Hu WenWei, Li Xue, Li Ji, Zhang Dan, Li ZhangZheng. Metabolic characteristics of nonalcoholic fatty liver disease and related risk factors in non-obese population[J]. Journal of Clinical Hepatology, 2020, 36(6): 1310-1313. doi: 10.3969/j.issn.1001-5256.2020.06.024
[14]	Yao ChengZi, Liu ZiZhen, Feng Gong, He Na, Mi Man. Risk factors for childhood nonalcoholic fatty liver disease and related prevention and management strategies[J]. Journal of Clinical Hepatology, 2020, 36(7): 1623-1626. doi: 10.3969/j.issn.1001-5256.2020.07.038
[15]	Yao ChengZi, Feng Gong, Yu WenSi, Du Huan, Mi Man. Risk factors for the development and progression of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2020, 36(2): 433-436. doi: 10.3969/j.issn.1001-5256.2020.02.044
[16]	Feng Gong, He Na, Mi Man, Li XuePing, Liu ManLing, Fan LiPing, Niu ChunYan. Risk factors for the coexistence of inflammatory bowel disease and nonalcoholic fatty liver disease: A Meta-analysis[J]. Journal of Clinical Hepatology, 2019, 35(4): 835-839. doi: 10.3969/j.issn.1001-5256.2019.04.025
[17]	Huang ZhiPeng, Jiang JianJia, Huang ZiCheng, Guo GuiYuan, Zhou APei, Liu XiaoQiang. Risk factors of nonalcoholic fatty liver disease with a normal visceral adipose tissue area[J]. Journal of Clinical Hepatology, 2019, 35(5): 1061-1064. doi: 10.3969/j.issn.1001-5256.2019.05.025
[18]	Ding YuPing, Li Hai, Zhang Wen, Xia ShiHai, Bi Xun. Epidemiological characteristics of nonalcoholic fatty liver disease with elevated alanine aminotransferase and related risk factors[J]. Journal of Clinical Hepatology, 2017, 33(12): 2355-2360. doi: 10.3969/j.issn.1001-5256.2017.12.020
[19]	Zhang JinHua, Long Hui, Liu Qun, Wang GuiFang. Analysis of risk factors of type 2 diabetes in patients with Nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2009, 25(2): 129-130.
[20]	Chen MingWei, Yang MingGong, Wang YouMin, Wang ZhangJiang, Pan TianRong, Hu HongLin, Sun HaiYan. Risk factors analysis on nonalcoholic steatohepatitis in patients with type 2 diabetes[J]. Journal of Clinical Hepatology, 2004, 20(1): 44-45.

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (2242) PDF downloads(420)

Logistic regression analysis of prognostic risk factors for hepatic encephalopathy

DOI: 10.3969/j.issn.1001-5256.2016.01.026

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Logistic regression analysis of prognostic risk factors for hepatic encephalopathy

DOI: 10.3969/j.issn.1001-5256.2016.01.026

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content